Literature DB >> 8732502

Rapid onset of lysophosphatidylcholine-induced modification of whole cell cardiac sodium current kinetics.

G S Shander1, A I Undrovinas, J C Makielski.   

Abstract

Lysophosphatidylcholine (LPC), an ischemic metabolite implicated in arrhythmogenesis, has been shown to modulate aspects of Na+ channel gating, but its effects on steady-state availability (h infinity), recovery from inactivation, and the timing of onset and possible reversibility, have not been characterized. We studied Na current (INa) by the whole-cell patch clamp technique on isolated rat ventricular myocytes at 22 degrees C with reduced Na+ (45 mM out, 5 mM in) from a holding potential of -150 mV. Changes in the electrophysiological parameters were measured after LPC 10 microM was added to the bath and compared to time controls (TC) taken from the time of seal formation. LPC decreased peak current for a test potential to -30 mV by about 20%. The peak current voltage relationship shifted in a positive direction by about 5 mV after LPC as compared to a small 2 mV negative shift in TC cells. LPC shifted the steady-state availability curve in the hyperpolarizing direction by about 6 mV. LPC perfusion caused a slowing of the decay of INa, and also a slowing of recovery from inactivation. Onset of the effects occurred within 6 min after adding LPC to the bath and were statistically significant with respect to TC cells between 12 and 16 min. In three cells, some of the effects on INa were either arrested or partially reversed by washout and cell survival was less than 20 min if LPC was not removed from the bath. These LPC induced changes in INa would tend to slow conduction and increase refractoriness, effects also seen in acutely ischemic myocardium. We therefore conclude that LPC action on INa may potentiate the arrhythmogenic substrate and that the onset of these changes are sufficiently rapid to play a role in the electrical instability of acute ischemia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8732502     DOI: 10.1006/jmcc.1996.0069

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  8 in total

Review 1.  Late sodium current in failing heart: friend or foe?

Authors:  Victor A Maltsev; Albertas Undrovinas
Journal:  Prog Biophys Mol Biol       Date:  2007-08-10       Impact factor: 3.667

Review 2.  Mechanisms of sudden cardiac death: oxidants and metabolism.

Authors:  Kai-Chien Yang; John W Kyle; Jonathan C Makielski; Samuel C Dudley
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

3.  Effects of arrhythmogenic lipid metabolites on the L-type calcium current of diabetic vs. non-diabetic rat hearts.

Authors:  M T Ziolo; K L Sondgeroth; C H Harshbarger; J M Smith; G M Wahler
Journal:  Mol Cell Biochem       Date:  2001-04       Impact factor: 3.396

Review 4.  Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart.

Authors:  Albertas Undrovinas; Victor A Maltsev
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2008-10

5.  Effects of duramycin on cardiac voltage-gated ion channels.

Authors:  Eva Zebedin; Xaver Koenig; Miroslav Radenkovic; Halyna Pankevych; Hannes Todt; Michael Freissmuth; Karlheinz Hilber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-01-05       Impact factor: 3.000

6.  Lipid bilayer-mediated regulation of ion channel function by amphiphilic drugs.

Authors:  Jens A Lundbaek
Journal:  J Gen Physiol       Date:  2008-04-14       Impact factor: 4.086

7.  Ranolazine and late cardiac sodium current--a therapeutic target for angina, arrhythmia and more?

Authors:  Jonathan C Makielski; Carmen R Valdivia
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

Review 8.  Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning.

Authors:  Sarah Rouhana; Anne Virsolvy; Nassim Fares; Sylvain Richard; Jérôme Thireau
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.